CASP1 and polycystic ovary syndrome: Overall, CASP-1 mRNA levels in SAT and VAT combined were significantly higher in non-PCOS participants (number of biopsies = 11) compared to those with PCOS (number of biopsies = 15) (median [IQR], 1.372 [1.131–1.454] vs. 0.3487 [0.03742–1.097], p = 0.036, respectively).